News about our Companies

Rhaeos, Inc. Receives FDA Breakthrough Device Designation for FlowSense™ Noninvasive Thermal Sensor

The Breakthrough Device Designation is supported by data from several recently published studies demonstrating effective use of FlowSense in detecting changes in cerebrospinal fluid volume and flow. By receiving this designation, Rhaeos will work in close collaboration with the FDA to streamline the market clearance process of FlowSense for this high-risk patient population.
Read More →

Arterys Raises $28 Million to Accelerate the Delivery of Medical AI to Practices Around the World

"The current crisis has shown us the necessity of a different approach to providing healthcare, where technology and AI are crucial for future success. Arterys is committed to transforming the way AI is integrated into the medical workflow, a promise that is long due in the industry. We recently launched our cloud platform and marketplace that will consolidate the work of thousands of AI models to be readily available for use by healthcare institutions around the globe," said Henry Weinstein, Managing Partner at Benslie International Ltd.
Read More →

Medtech Startup Promaxo Raises First Tranche of Series B-1 Funding

Promaxo, an Oakland-based medical technology startup developing the portable single-sided MRI, today announced that it has raised the first tranche of Series B-1 funding. The equity round was led by Kineticos Disruptor Fund with participation from existing investors. Launched in 2016, Promaxo plans to revolutionize healthcare with its MR imaging and robotic platform.
Read More →

Neural Analytics aims robotic transcranial doppler at COVID-19 patients

Doctors are reporting a proliferation of dangerous blood clots in the lungs and other major organs of COVID-19 patients, raising the risk of stroke and other life-threatening complications. While anticoagulant medications can reduce that risk, patients need careful monitoring to ensure their blood is neither too thick nor too thin. To that end, Los Angeles-based startup Neural Analytics Inc. is deploying its robotically assisted transcranial doppler (TCD) system for real-time identification of blood clots and disruptions in blood flow to the brain.
Read More →